News
Author: admin als-handoff
-
Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation
BOTHELL, Wash and VANCOUVER, British Columbia, Nov. 28, 2017 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced an agreement with Auckland UniServices Limited, as the commercial arm of the University of Auckland, to provide cytisine for use in…
-
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects
BOTHELL, Wash and VANCOUVER, British Columbia, NOV. 14, 2017 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clinical study evaluating the effect of food on the bioavailability of 3mg cytisine. The study evaluated the bioavailability…
-
Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017
BOTHELL, Wash and VANCOUVER, British Columbia, November 8, 2017 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference being held on…
-
Achieve Announces Availability of Company Presentation from the Virtual Investor Conference
BOTHELL, Wash and VANCOUVER, British Columbia, November 6, 2017 – Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the November 2nd presentation given by Rick Stewart, Chairman and Chief Executive Officer, is now available for on-demand viewing at…
-
Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017
Company invites individual and institutional investors and advisors to attend virtualinvestorconferences.com. BOTHELL, Wash and VANCOUVER, British Columbia, Oct. 30, 2017 – Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will be…